Supply Chain Interruptions/ Recalls

Supply Chain Interruptions/ Recalls

Welcome to our dedicated page for Supply Chain Interruptions and Recalls in the dialysis industry. Here, you'll find the latest updates and critical information about disruptions and recalls affecting dialysis supplies and equipment. Our goal is to keep you informed and prepared, ensuring that you can manage your operations smoothly and maintain the highest standards of patient care despite unforeseen challenges. 

Last updated 11/19/25.

CLICK HERE TO SUBMIT UPDATES 

.

Recalls

November 19: Recall, Update to Use Instructions for B. Braun Hemodialysis Blood Tubing Set

  • This recall involves updating instructions for using certain devices and does not involve removing them.

October 7: Trividia Health Initiatates Voluntary Recall of Limited Number of TRUE METRIX Blood Glucose Meters

September 12: BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets

.

Corrections

August 15: KCER - FDA Early Alert: Infusion Pump Issue from Baxter

  • The FDA is aware that Baxter has issued a letter to affected customers recommending all Novum IQ Large
    Volume Pumps (LVP) and Novum IQ Syringe Pumps (SP) be corrected prior to continued use.

.

Interruptions

September 10: Early Alert: TactiFlex Ablation Catheter Issue from Abbott

  • The FDA is aware that Abbott has issued a letter to affected customers recommending updated instructions when removing the TactiFlex Ablation Catheter, Sensor Enabled from its packaging.

.

Drug Shortages

November 11 (Revised): Hospira, Dobutamine Hydrochloride, Unavailable or discontinued. 

Unavailable

  • In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL, 500 mg/250mL, and 1,000 mg/250mL. 
    • Next Delivery April 2026. Estimated Recovery June 2026
  • Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88). Next delivery and estimated recovery December 2027. 

Discontinued (Aug 27):

November 7 (Revised): Cipla Limited, Hydrocortisone Sodium Succinate, Injection. Limited Availability, 1-3 months. 

.

Discontinuations

July 17: Watson Pharma Private Limited, Potassium Citrate Tablet, Extended Release

June 10: Fresenius Medical Care, Sodium Chloride 0.9% Injection

May 14: Upsher-Smith Laboratories, LLC, Oxybutynin Chloride, Tablet, 5 mg

.

.

If you have information on a dialysis-related supply chain interruption, recall, correction, shortage, or discontinuation, please submit here.

If you have any questions, please contact marketing@renalhealthcare.org.

.